Takamichi Mito

Strong Room Technology Pty Ltd. provides electronic controlled drug register (ECDR), opioid replacement therapy (OTP/ORT), staged supply, e-prescribing, administration reporting, pharmacy ward theatre configuration & notification, and enterprise reporting. The company is based in Melbourne, Australia. The Australian company's system uses human-centric design principles and has adjustable modules for medication management based on context and care provider needs. The company prioritizes user feedback in product development to ensure that their products, tools, systems, and platform align with customer needs and preferences through customer co-creation. The company was founded in 2017 by Mark Feldschuh, Max Mito, Chris Durre, Kieran Start. Max Mito has been the CEO since 2017.